Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases

Citation
Aj. Fox et al., Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases, EUR J PHARM, 424(2), 2001, pp. 159-162
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
424
Issue
2
Year of publication
2001
Pages
159 - 162
Database
ISI
SICI code
0014-2999(20010720)424:2<159:RONGFB>2.0.ZU;2-C
Abstract
Elevated levels of nerve growth factor (NGF) have been detected in the bron choalveolar lavage fluid of patients with asthma. However, the source of th is enhanced mediator production is not known. Here, we investigate the prod uction of NGF from a human airway epithelial cell line (A549). Under basal conditions, A549 cells generated NGF in a time-dependent fashion. However, basal release was significantly augmented in a concentration-dependent mann er in cells treated with interleukin-1 beta (IL-1 beta) or tumour necrosis factor-alpha (TNF-alpha) and inhibited by dexamethasone. These data suggest that NGF released from structural cells may be an important target for the anti-inflammatory effects of steroids in asthma therapy. (C) 2001 Elsevier Science B.V. All rights reserved.